Bicycle Other Assets vs Total Current Assets Analysis
BCYC Stock | USD 23.03 0.45 1.92% |
Bicycle Therapeutics financial indicator trend analysis is way more than just evaluating Bicycle Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bicycle Therapeutics is a good investment. Please check the relationship between Bicycle Therapeutics Other Assets and its Total Current Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bicycle Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. For information on how to trade Bicycle Stock refer to our How to Trade Bicycle Stock guide.
Other Assets vs Total Current Assets
Other Assets vs Total Current Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bicycle Therapeutics Other Assets account and Total Current Assets. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Bicycle Therapeutics' Other Assets and Total Current Assets is 0.93. Overlapping area represents the amount of variation of Other Assets that can explain the historical movement of Total Current Assets in the same time period over historical financial statements of Bicycle Therapeutics, assuming nothing else is changed. The correlation between historical values of Bicycle Therapeutics' Other Assets and Total Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Assets of Bicycle Therapeutics are associated (or correlated) with its Total Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Assets has no effect on the direction of Other Assets i.e., Bicycle Therapeutics' Other Assets and Total Current Assets go up and down completely randomly.
Correlation Coefficient | 0.93 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Other Assets
Total Current Assets
The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.Most indicators from Bicycle Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bicycle Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bicycle Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. For information on how to trade Bicycle Stock refer to our How to Trade Bicycle Stock guide.At present, Bicycle Therapeutics' Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 267.8 M, whereas Sales General And Administrative To Revenue is forecasted to decline to 1.89.
Bicycle Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Bicycle Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bicycle Therapeutics fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 110.2M | 161.2M | 479.8M | 410.6M | 595.3M | 625.1M | |
Other Current Liab | 5.5M | 10.8M | 11.9M | 23.3M | 26.6M | 28.0M | |
Total Current Liabilities | 8.8M | 23.1M | 36.2M | 53.3M | 69.5M | 73.0M | |
Total Stockholder Equity | 93.2M | 95.5M | 346.3M | 270.8M | 370.9M | 389.5M | |
Other Liab | 6.9M | 27.6M | 55.3M | 45.3M | 52.1M | 26.8M | |
Net Tangible Assets | 93.2M | 95.5M | 346.3M | 270.8M | 311.4M | 327.0M | |
Retained Earnings | (100.6M) | (151.6M) | (218.4M) | (331.1M) | (511.8M) | (486.2M) | |
Accounts Payable | 1.9M | 1.4M | 2.7M | 6.5M | 13.1M | 13.7M | |
Cash | 92.1M | 136.0M | 438.7M | 339.2M | 526.4M | 552.7M | |
Other Assets | 1.7M | 3.1M | 3.4M | 8.5M | 9.7M | 10.2M | |
Cash And Short Term Investments | 92.1M | 136.0M | 438.7M | 339.2M | 526.4M | 552.7M | |
Net Receivables | 7.1M | 14.6M | 11.9M | 21.2M | 24.0M | 13.0M | |
Common Stock Total Equity | 5K | 10K | 227K | 266K | 305.9K | 321.2K | |
Other Current Assets | 4.9M | 5.1M | 8.0M | 9.0M | 11.4M | 12.0M | |
Other Stockholder Equity | 195.1M | 249.9M | 567.6M | 601.1M | 883.4M | 927.6M | |
Total Liab | 17.0M | 65.7M | 133.5M | 139.8M | 224.4M | 117.8M | |
Total Current Assets | 104.1M | 155.7M | 458.6M | 369.4M | 561.9M | 590.0M | |
Accumulated Other Comprehensive Income | (1.5M) | (3.2M) | (3.4M) | 387K | (1.3M) | (1.4M) | |
Short Term Debt | 640K | 844K | 2.4M | 3.1M | 4.9M | 5.1M | |
Common Stock | 227K | 266K | 384K | 387K | 550K | 577.5K | |
Property Plant Equipment | 4.3M | 3.6M | 17.8M | 32.8M | 37.7M | 39.6M | |
Property Plant And Equipment Net | 4.3M | 3.6M | 17.8M | 32.8M | 27.7M | 14.0M | |
Current Deferred Revenue | 728K | 10.1M | 19.3M | 20.4M | 25.0M | 12.5M | |
Net Debt | (90.2M) | (120.2M) | (394.3M) | (294.8M) | (481.5M) | (457.4M) | |
Non Current Assets Total | 6.0M | 5.4M | 21.2M | 41.2M | 33.5M | 18.0M | |
Non Currrent Assets Other | 1.7M | 1.8M | 3.4M | 8.5M | 5.2M | 3.9M | |
Common Stock Shares Outstanding | 11.0M | 19.1M | 25.1M | 29.7M | 35.6M | 23.1M | |
Liabilities And Stockholders Equity | 110.2M | 161.2M | 479.8M | 410.6M | 595.3M | 300.6M | |
Non Current Liabilities Total | 8.2M | 42.6M | 97.3M | 86.5M | 154.9M | 101.1M | |
Net Invested Capital | 93.2M | 110.0M | 376.1M | 301.1M | 401.6M | 421.7M | |
Property Plant And Equipment Gross | 4.3M | 3.6M | 22.6M | 40.6M | 41.1M | 43.1M | |
Non Current Liabilities Other | 2.0M | 2.6M | 3.3M | 3.8M | 4.6M | 2.8M | |
Net Working Capital | 95.3M | 132.6M | 422.3M | 316.0M | 492.3M | 249.6M | |
Capital Stock | 227K | 266K | 384K | 387K | 550K | 334.4K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.MSFT | Microsoft | |
GM | General Motors | |
CRM | Salesforce |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bicycle Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. For information on how to trade Bicycle Stock refer to our How to Trade Bicycle Stock guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for Bicycle Stock analysis
When running Bicycle Therapeutics' price analysis, check to measure Bicycle Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bicycle Therapeutics is operating at the current time. Most of Bicycle Therapeutics' value examination focuses on studying past and present price action to predict the probability of Bicycle Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bicycle Therapeutics' price. Additionally, you may evaluate how the addition of Bicycle Therapeutics to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Stocks Directory Find actively traded stocks across global markets | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is Bicycle Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bicycle Therapeutics. If investors know Bicycle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bicycle Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.40) | Revenue Per Share 1.074 | Quarterly Revenue Growth 2.989 | Return On Assets (0.23) | Return On Equity (0.56) |
The market value of Bicycle Therapeutics is measured differently than its book value, which is the value of Bicycle that is recorded on the company's balance sheet. Investors also form their own opinion of Bicycle Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Bicycle Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bicycle Therapeutics' market value can be influenced by many factors that don't directly affect Bicycle Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bicycle Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bicycle Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bicycle Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.